A case with primary central nervous system lymphoma treated with chemotherapy on the basis of the multidrug resistance gene mRNA expression

Japanese Journal of Neurosurgery

Volumn 10, Issue 7, 2001, Pages 469-474

  Kunishio, K ^a   Matsumoto, Y ^a   Morisaki, K ^a   Kawakita, K ^a   Miyake, K ^a   Nagao, S ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Central nervous system lymphoma; Multidrug resistance gene; MXR1

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); MESSENGER RNA; METHOTREXATE; MITOXANTRONE; MITOXANTRONE RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE 1; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; PREDNISOLONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; B CELL LYMPHOMA; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG MEGADOSE; FEMALE; GENE EXPRESSION; HEMIPARESIS; HUMAN; MULTIDRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY;

EID: 0034943115     PISSN: 0917950X     EISSN: None     Source Type: Journal    
DOI: 10.7887/jcns.10.469     Document Type: Article

References (24)

1. Unknotting the complexities of multidrug resistance: The involvement of DNA topoisomerases in drug action and resistance
2. The multidrug-resistance gene MDR1 is expressed in human glial tumors
3. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system: Preliminary data
4. Overexpression of a transporter gene in a multidrug-resistance human lung cancer cell line
5. Combined modality therapy for primary CNS lymphoma
6. Expression of a multidrug-resistance gene in human tumors and tissues
7. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome
8. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
9. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas
10. Analysis of expression of cMOAT, (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
11. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression
12. Cellular adaptation to drug exposure: Evolution of the drug-resistant phenotype
13. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma
14. 6-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy
15. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
16. 6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors
17. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma
18. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes